# A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer

> **NCT03796429** · PHASE2 · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 50 (actual)

## Conditions studied

- Biliary Tract Cancer

## Interventions

- **DRUG:** GS+Toripalimab

## Key facts

- **NCT ID:** NCT03796429
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-17
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-03-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03796429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03796429, "A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03796429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*